Actively Recruiting
Utility of Mucosal Impedance Device in Chronic Esophageal Disorders:
Led by Medical College of Wisconsin · Updated on 2025-11-13
50
Participants Needed
1
Research Sites
136 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Background \& Significance Chronic benign esophageal disorders such as Gastroesophageal reflux disease (GERD) and eosinophilic esophagitis are common gastrointestinal disorders affecting nearly 20% and 0.1% of the population, respectively. Although these conditions are frequent, the diagnosis of GERD or EoE requires complex decision making involving endoscopic examination, histopathological examination, and esophageal pH testing. This translates into significant economic burden; For example, burden due to GERD is about $24 billion annually. Additionally, there may be a delay in the diagnosis of GERD or EoE as Investigators might have to do multiple procedures such as upper endoscopy, esophageal pH testing, etc for the same participant for confirmation of the diagnosis. In addition, there could be overlay between GERD and EoE in the diagnosis which make cause delay in the diagnosis and decision making. Aim: Here, Investigators will plan to identify the diagnostic utility and cost-effectiveness of this novel Mivu device(FDA approved) in the diagnosis of gastroesophageal reflux disease or chronic esophageal inflammatory disorders in participants with reflux symptoms or chronic esophageal symptoms.
CONDITIONS
Official Title
Utility of Mucosal Impedance Device in Chronic Esophageal Disorders:
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with chronic esophageal symptoms such as typical or atypical reflux symptoms or difficulty swallowing who are scheduled for upper endoscopy.
You will not qualify if you...
- Presence of esophageal stricture.
- Unstable condition preventing testing.
- Use of anticoagulation medication on the day of procedure.
- Presence of esophageal cancer.
- Pregnancy.
- Minor patients (under 18 years old).
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Froedtert Hospital
Milwaukee, Wisconsin, United States, 53226
Actively Recruiting
Research Team
G
Gokulakrishnan Balasubramanian
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here